314 related articles for article (PubMed ID: 18637019)
1. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action.
Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019
[TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
3. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits.
Liu Y; Zhang HG; Jia Y; Li XH
Biol Pharm Bull; 2010; 33(8):1324-30. PubMed ID: 20686226
[TBL] [Abstract][Full Text] [Related]
4. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression.
Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT
J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
6. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
7. 2,3,4',5-Tetrahydroxystilbene-2-O-beta-D-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats.
Zhang W; Wang CH; Li F; Zhu WZ
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):310-6. PubMed ID: 17973930
[TBL] [Abstract][Full Text] [Related]
8. Protective Effect of Panax Notoginseng Saponins on Apolipoprotein-E-deficient Atherosclerosis-prone Mice.
Yang H; Liu Z; Hu X; Liu X; Gui L; Cai Z; Dai C
Curr Pharm Des; 2022; 28(8):671-677. PubMed ID: 35088656
[TBL] [Abstract][Full Text] [Related]
9. Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats.
Rong L; Chen Y; He M; Zhou X
Respirology; 2009 Aug; 14(6):890-8. PubMed ID: 19659831
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Panax notoginseng saponins on vascular intima hyperplasia and PCNA expression in rat aorta after balloon angioplasty].
Wang J; Wu L; Zhang W; Deng C
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):735-9. PubMed ID: 19624018
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice].
Yang CY; Xie ZG; Cheng WB; Jiang X; Chen ZH
Zhong Yao Cai; 2009 Oct; 32(10):1571-6. PubMed ID: 20112724
[TBL] [Abstract][Full Text] [Related]
12. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway.
Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components.
Yang CY; Wang J; Zhao Y; Shen L; Jiang X; Xie ZG; Liang N; Zhang L; Chen ZH
J Ethnopharmacol; 2010 Jul; 130(2):231-6. PubMed ID: 20435129
[TBL] [Abstract][Full Text] [Related]
14. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
15. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.
Du YG; Wang LP; Qian JW; Zhang KN; Chai KF
Chin J Integr Med; 2016 Dec; 22(12):910-917. PubMed ID: 26712211
[TBL] [Abstract][Full Text] [Related]
16. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis.
Peng XD; Dai LL; Huang CQ; He CM; Yang B; Chen LJ
Biochem Biophys Res Commun; 2009 Oct; 388(1):31-4. PubMed ID: 19632202
[TBL] [Abstract][Full Text] [Related]
17. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats.
Park WH; Lee SK; Kim CH
Life Sci; 2005 Feb; 76(15):1675-90. PubMed ID: 15698847
[TBL] [Abstract][Full Text] [Related]
18. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats].
Jin HF; Liang C; Liang JM; Tang CS; DU JB
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2235-9. PubMed ID: 19087668
[TBL] [Abstract][Full Text] [Related]
19. Effect of Panax notoginseng saponins on lipopolysaccharide-induced adhesion of leukocytes in rat mesenteric venules.
Sun K; Wang CS; Guo J; Liu YY; Wang F; Liu LY; He JG; Fan JY; Han JY
Clin Hemorheol Microcirc; 2006; 34(1-2):103-8. PubMed ID: 16543624
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice.
Liu L; Shi R; Shi Q; Cheng Y; Huo Y
Planta Med; 2008 Feb; 74(3):203-9. PubMed ID: 18260050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
